News
In a strong debut, Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback